NCT04609579 2024-01-30Study of SNX281 in Subjects With Advanced Solid Tumors and LymphomaStingthera, Inc.Phase 1 Terminated27 enrolled
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled